TOLERACYTE Trademark

Trademark Overview

On Monday, April 6, 2020, a trademark application was filed for TOLERACYTE with the United States Patent and Trademark Office. The USPTO has given the TOLERACYTE trademark a serial number of 88861225. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 30, 2023. This trademark is owned by Fate Therapeutics, Inc.. The TOLERACYTE trademark is filed in the Pharmaceutical Products category with the following description:

stem cells for medical purposes; therapeutic cell preparation for the treatment of auto-immune diseases, and inflammatory and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies
toleracyte

General Information

Serial Number88861225
Word MarkTOLERACYTE
Filing DateMonday, April 6, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and Servicesstem cells for medical purposes; therapeutic cell preparation for the treatment of auto-immune diseases, and inflammatory and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, October 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, February 22, 2023SOU EXTENSION 5 FILED
Tuesday, March 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Saturday, September 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2022SOU EXTENSION 4 GRANTED
Thursday, September 15, 2022SOU EXTENSION 4 FILED
Thursday, September 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 3 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 3 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 2 GRANTED
Thursday, September 16, 2021SOU EXTENSION 2 FILED
Thursday, September 16, 2021SOU TEAS EXTENSION RECEIVED
Saturday, March 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 25, 2021SOU EXTENSION 1 GRANTED
Thursday, March 25, 2021SOU EXTENSION 1 FILED
Thursday, March 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2020ASSIGNED TO EXAMINER
Wednesday, April 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2020NEW APPLICATION ENTERED

Related Keywords

toleracyte immune therapeutic cells inflammatory diseases disorders agents modulation immunotherapies treatment